Pharma stocks came under selling pressure in early trades on Friday after US President Donald Trump announced a 100 per cent tariffs on branded pharmaceutical products, starting October 1.

Pharma stocks declined as much as 5 per cent and Nifty Pharma index plunged 2.67 per cent. Sun Pharma declined 4.89 per cent, Biocon decreased 3.77 per cent, Abbott India Ltd slipped 3.46 per cent, Lupin fell 2.47 per cent and Cipla dipped 2.28 per cent in the early morning trades. Dr Reddy’s and Aurobindo Pharma declined 2.27 per cent, and Zydus Lifesciences was down 3.36 per cent.

“Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America,” Trump said in a post on Tr

See Full Page